CryoPort (CYRX)
(Delayed Data from NSDQ)
$16.81 USD
+0.62 (3.83%)
Updated May 1, 2024 04:00 PM ET
4-Sell of 5 4
F Value D Growth D Momentum F VGM
Brokerage Reports
0 items in cart
CryoPort, Inc. [CYRX]
Reports for Purchase
Showing records 41 - 60 ( 192 total )
Company: CryoPort, Inc.
Industry: Transportation - Services
Company: CryoPort, Inc.
Industry: Transportation - Services
Significant Revenue Step Up in 2Q22; More Records Expected Near-Term
Provider: Roth Capital Partners, Inc.
Analyst: BALDRY R
Company: CryoPort, Inc.
Industry: Transportation - Services
Company: CryoPort, Inc.
Industry: Transportation - Services
Company: CryoPort, Inc.
Industry: Transportation - Services
Cell & Gene Therapy Logistics Showing Momentum in 2Q
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: CryoPort, Inc.
Industry: Transportation - Services
Company: CryoPort, Inc.
Industry: Transportation - Services
Company: CryoPort, Inc.
Industry: Transportation - Services
Sideways Trend Could Set Sector Bottom With Good 2Q22 Results Expected
Provider: Roth Capital Partners, Inc.
Analyst: Research Department
Company: CryoPort, Inc.
Industry: Transportation - Services
Software: Upcoming London Conference Offers Timely Access
Provider: Roth Capital Partners, Inc.
Analyst: BALDRY R
Company: CryoPort, Inc.
Industry: Transportation - Services
High Beta Macro Attack Mistakenly Targets Defensible Fast-Growers
Provider: Roth Capital Partners, Inc.
Analyst: BALDRY R
Company: CryoPort, Inc.
Industry: Transportation - Services
Company: CryoPort, Inc.
Industry: Transportation - Services
When Smoke Clears, Growth Appears Likely To Accelerate
Provider: Roth Capital Partners, Inc.
Analyst: BALDRY R
Company: CryoPort, Inc.
Industry: Transportation - Services
Company: CryoPort, Inc.
Industry: Transportation - Services
Cell & Gene Therapy Logistics Showing Momentum in 1Q
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: CryoPort, Inc.
Industry: Transportation - Services
Company: CryoPort, Inc.
Industry: Transportation - Services
Company: CryoPort, Inc.
Industry: Transportation - Services
Bioproduction: Tool Shares Weak but More Cell Therapy Catalysts
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: CryoPort, Inc.
Industry: Transportation - Services
Company: CryoPort, Inc.
Industry: Transportation - Services
2022 Life Sciences & MedTech Investor Forum
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: CryoPort, Inc.
Industry: Transportation - Services
2022 Life Sciences and MedTech Conference: Day 1 Takeaways
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department